FINNENCE ▪ THE WIRE FILE
THE WIRE · № 60915
Company■ Unclear/unknown
Phase 3 results posted: Atacicept in Subjects With IgA Nephropathy — Vera Therapeutics, Inc.
KINDCompany
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-01 12:00 UTC
LAST UPDATE2026-10-01 12:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Atacicept Phase 3 results in IgA nephropathy could support Vera's lead program, but outcomes are unstated.
Key readout for Vera's lead candidate
CATALYST TO WATCH
Full efficacy data and FDA submission
MAIN RISK
Results may miss endpoints
FULL DISPATCH
Sponsor: Vera Therapeutics, Inc.; Status: Active Not Recruiting; Conditions: IgA Nephropathy, Berger Disease; Interventions: Atacicept, Placebo to match Atacicept; Enrollment: 428 (actual); First posted: 2021-01-20; Results posted: 2026-10-01; NCT: NCT04716231
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Phase 3 results posted: A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia — Biosplice Therapeutics, Inc.2026-10-01 12:00 UTC
Phase 3 results posted: A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia — Biosplice Therapeutics, Inc.2026-10-01 12:00 UTC
→CORRELATIONshares Healthcare
Phase 3 results posted: Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III) — BioXcel Therapeutics Inc2026-10-01 12:00 UTC
Phase 3 results posted: Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III) — BioXcel Therapeutics Inc2026-10-01 12:00 UTC
→CORRELATIONshares Healthcare
Phase 3 results posted: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis — Abcuro, Inc.2026-10-01 12:00 UTC
Phase 3 results posted: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis — Abcuro, Inc.2026-10-01 12:00 UTC
→CORRELATIONshares Healthcare
Quadria-backed Maxivision confidentially files for India IPO2026-10-01 23:00 UTC
Quadria-backed Maxivision confidentially files for India IPO2026-10-01 23:00 UTC
→CORRELATIONshares Healthcare
Supreme Court denies Arizona’s bid to delay start of takeover of healthcare in state prisons2026-10-01 17:58 UTC
Supreme Court denies Arizona’s bid to delay start of takeover of healthcare in state prisons2026-10-01 17:58 UTC
←CORRELATIONshares Healthcare
Avanos Medical, Inc. Launches Game Ready® Over-the-Counter Recovery System in the U.S.2026-10-01 11:00 UTC
Avanos Medical, Inc. Launches Game Ready® Over-the-Counter Recovery System in the U.S.2026-10-01 11:00 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.